Home Compare AZN.L vs EUZ.DE
Stock Comparison · Comparison

AstraZeneca vs Eckert & Ziegler: Which Stock Looks Stronger in 2026?

Eckert & Ziegler SE holds the cleaner structural position, with the lead spread across stability and profitability. AstraZeneca still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, AstraZeneca carries the stronger setup — intact trend against Eckert & Ziegler SE's broken trend. That leaves a split case: the structural lead stays with Eckert & Ziegler SE, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The page question resolves through stability, where AstraZeneca PLC holds the stronger read even though the broader score still favours Eckert & Ziegler SE.

Trajectory Similarity
0.65
Moderately similar
Peer-set rank: #6
within AstraZeneca PLC's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The match is driven mainly by revenue growth trajectory and capital structure.

Similarity drivers
revenue growth trajectorycapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AZN.L
AstraZeneca PLC
49
Peer-Score
Signal qualityHigh
vs
EUZ.DE
Eckert & Ziegler SE
56
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: AZN.L vs EUZ.DE Profitability 41 78 Stability 65 11 Valuation 39 69 Growth 59 50 AZN.L EUZ.DE
Gap Ranking
#1 Stability +54
#2 Profitability +37
#3 Valuation +30
#4 Growth +9
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AZN.L and EUZ.DE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AZN.LEUZ.DE Relative valuation Structural strength

AstraZeneca PLC looks stronger, but the price setup still looks more supportive for Eckert & Ziegler SE.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
AstraZeneca PLC ranks near the top of the group on stability; Eckert & Ziegler SE sits in the weaker half.
Profitability
On profitability, the same pattern holds: both are strong, but Eckert & Ziegler SE still leads clearly.
Stability — Dominant Gap
AZN.L
65
EUZ.DE
11
Gap+54in favour of AZN.L

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

AstraZeneca PLC still looks less cycle-sensitive — that keeps the result from looking completely one-sided.

What this means for the comparison

The lead is built on both stability and profitability — though stability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the AZN.L vs EUZ.DE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how AZN.L and EUZ.DE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.